chr16:52552429:A>G Detail (hg38)
Information
Genome
| Assembly | Position |
|---|---|
| hg19 | chr16:52,586,341-52,586,341 View the variant detail on this assembly version. |
| hg38 | chr16:52,552,429-52,552,429 |
HGVS
[No Data.]
Summary
MGeND
| Clinical significance | |
| Variant entry | |
| GWAS entry | |
| Disease area statistics | Show details |
Frequency
| JP | HGVD:[No Data.] |
| ToMMo:0.476 | |
| NCBN:[No Data.] | |
| NCBN(Hondo):[No Data.] | |
| NCBN(Ryukyu):[No Data.] | |
| East asia | ExAC:[No Data.] |
Prediction
ClinVar
| Clinical Significance | |
| Review star | [No Data.] |
| Show details | |
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
[No Data.]
DisGeNET
| Score | Disease name | Description | Source | Pubmed | Links |
|---|---|---|---|---|---|
| 0.006 | breast carcinoma | We focus on TNRC9 rs3803662, FGFR2 rs1219648 and rs2981582, MAP3K1 rs889312, and... | BeFree | 21475998 | Detail |
| 0.166 | Malignant neoplasm of breast | We focus on TNRC9 rs3803662, FGFR2 rs1219648 and rs2981582, MAP3K1 rs889312, and... | BeFree | 21475998 | Detail |
| 0.162 | Malignant neoplasm of breast | Six of the previously identified SNPs showed a statistically significant associa... | BeFree | 22867275 | Detail |
| 0.166 | Malignant neoplasm of breast | Six of the previously identified SNPs showed a statistically significant associa... | BeFree | 22867275 | Detail |
| 0.031 | breast carcinoma | Six of the previously identified SNPs showed a statistically significant associa... | BeFree | 22867275 | Detail |
| 0.010 | breast carcinoma | Six of the previously identified SNPs showed a statistically significant associa... | BeFree | 22867275 | Detail |
| 0.004 | breast carcinoma | Six of the previously identified SNPs showed a statistically significant associa... | BeFree | 22867275 | Detail |
| 0.006 | breast carcinoma | Six of the previously identified SNPs showed a statistically significant associa... | BeFree | 22867275 | Detail |
| 0.170 | Malignant neoplasm of breast | Six of the previously identified SNPs showed a statistically significant associa... | BeFree | 22867275 | Detail |
| 0.230 | Malignant neoplasm of breast | Six of the previously identified SNPs showed a statistically significant associa... | BeFree | 22867275 | Detail |
| <0.001 | breast carcinoma | We genotyped 17 germline SNPs (FGFR2-rs2981582, FGFR2-rs3750817, TNRC9-rs3803662... | BeFree | 21791674 | Detail |
| 0.132 | Malignant neoplasm of breast | We genotyped 17 germline SNPs (FGFR2-rs2981582, FGFR2-rs3750817, TNRC9-rs3803662... | BeFree | 21791674 | Detail |
| 0.024 | Triple Negative Breast Neoplasms | We identified six single-nucleotide polymorphisms, including rs2046210 (ESR1), r... | BeFree | 21844186 | Detail |
| <0.001 | Triple Negative Breast Neoplasms | We identified six single-nucleotide polymorphisms, including rs2046210 (ESR1), r... | BeFree | 21844186 | Detail |
| <0.001 | Triple Negative Breast Neoplasms | We identified six single-nucleotide polymorphisms, including rs2046210 (ESR1), r... | BeFree | 21844186 | Detail |
| 0.001 | breast carcinoma | We genotyped 17 germline SNPs (FGFR2-rs2981582, FGFR2-rs3750817, TNRC9-rs3803662... | BeFree | 21791674 | Detail |
| 0.001 | Malignant neoplasm of breast | We genotyped 17 germline SNPs (FGFR2-rs2981582, FGFR2-rs3750817, TNRC9-rs3803662... | BeFree | 21791674 | Detail |
| 0.003 | breast carcinoma | We genotyped 17 germline SNPs (FGFR2-rs2981582, FGFR2-rs3750817, TNRC9-rs3803662... | BeFree | 21791674 | Detail |
| 0.128 | Malignant neoplasm of breast | Genome-wide association study of breast cancer in the Japanese population. | GWASCAT | 24143190 | Detail |
| 0.123 | Malignant neoplasm of breast | We genotyped 17 germline SNPs (FGFR2-rs2981582, FGFR2-rs3750817, TNRC9-rs3803662... | BeFree | 21791674 | Detail |
| 0.360 | Malignant neoplasm of breast | In the present study, we evaluated the association between rs3803662 (TOX3, also... | BeFree | 24532140 | Detail |
| 0.080 | breast carcinoma | In the present study, we evaluated the association between rs3803662 (TOX3, also... | BeFree | 24532140 | Detail |
| <0.001 | Malignant neoplasm of female breast | Comparing the ORs for male breast cancer with the published ORs for female breas... | BeFree | 21949660 | Detail |
| <0.001 | Carcinoma of male breast | Comparing the ORs for male breast cancer with the published ORs for female breas... | BeFree | 21949660 | Detail |
| <0.001 | female breast carcinoma | Comparing the ORs for male breast cancer with the published ORs for female breas... | BeFree | 21949660 | Detail |
| <0.001 | Malignant neoplasm of male breast | Comparing the ORs for male breast cancer with the published ORs for female breas... | BeFree | 21949660 | Detail |
| <0.001 | Malignant neoplasm of male breast | Comparing the ORs for male breast cancer with the published ORs for female breas... | BeFree | 21949660 | Detail |
| <0.001 | female breast carcinoma | Comparing the ORs for male breast cancer with the published ORs for female breas... | BeFree | 21949660 | Detail |
| <0.001 | Carcinoma of male breast | Comparing the ORs for male breast cancer with the published ORs for female breas... | BeFree | 21949660 | Detail |
| <0.001 | Malignant neoplasm of female breast | Comparing the ORs for male breast cancer with the published ORs for female breas... | BeFree | 21949660 | Detail |
| <0.001 | Malignant neoplasm of male breast | By multivariate logistic regression models, we found a significant increased MBC... | BeFree | 23468243 | Detail |
| <0.001 | Carcinoma of male breast | By multivariate logistic regression models, we found a significant increased MBC... | BeFree | 23468243 | Detail |
| <0.001 | Malignant neoplasm of male breast | By multivariate logistic regression models, we found a significant increased MBC... | BeFree | 23468243 | Detail |
| <0.001 | Carcinoma of male breast | By multivariate logistic regression models, we found a significant increased MBC... | BeFree | 23468243 | Detail |
| <0.001 | ovarian carcinoma | Initially, three SNPs (rs2107425 in MRPL23, rs7313833 in PTHLH, rs3803662 in TNR... | BeFree | 19304784 | Detail |
| <0.001 | ovarian carcinoma | Initially, three SNPs (rs2107425 in MRPL23, rs7313833 in PTHLH, rs3803662 in TNR... | BeFree | 19304784 | Detail |
| <0.001 | ovarian carcinoma | Initially, three SNPs (rs2107425 in MRPL23, rs7313833 in PTHLH, rs3803662 in TNR... | BeFree | 19304784 | Detail |
| 0.003 | Malignant neoplasm of ovary | Initially, three SNPs (rs2107425 in MRPL23, rs7313833 in PTHLH, rs3803662 in TNR... | BeFree | 19304784 | Detail |
| <0.001 | ovarian carcinoma | Initially, three SNPs (rs2107425 in MRPL23, rs7313833 in PTHLH, rs3803662 in TNR... | BeFree | 19304784 | Detail |
| 0.003 | Malignant neoplasm of ovary | Initially, three SNPs (rs2107425 in MRPL23, rs7313833 in PTHLH, rs3803662 in TNR... | BeFree | 19304784 | Detail |
| <0.001 | Malignant neoplasm of ovary | Initially, three SNPs (rs2107425 in MRPL23, rs7313833 in PTHLH, rs3803662 in TNR... | BeFree | 19304784 | Detail |
| 0.003 | Malignant neoplasm of ovary | Initially, three SNPs (rs2107425 in MRPL23, rs7313833 in PTHLH, rs3803662 in TNR... | BeFree | 19304784 | Detail |
| 0.121 | Mammographic Density | Evidence of association with MD was found for variant rs3803662 (TOX3) (Odds Rat... | BeFree | 23021931 | Detail |
| 0.031 | breast carcinoma | We also confirmed that SNPs in FGFR2 and TNRC9 were associated with greater risk... | BeFree | 21791674 | Detail |
| 0.170 | Malignant neoplasm of breast | We also confirmed that SNPs in FGFR2 and TNRC9 were associated with greater risk... | BeFree | 21791674 | Detail |
| 0.240 | Malignant neoplasm of breast | Odds ratios for breast cancer were greatest for FGFR2-rs2981582 and TNRC9-rs3803... | BeFree | 20664043 | Detail |
| 0.010 | breast carcinoma | Odds ratios for breast cancer were greatest for FGFR2-rs2981582 and TNRC9-rs3803... | BeFree | 20664043 | Detail |
| <0.001 | Mammographic Density | Evidence of association with MD was found for variant rs3803662 (TOX3) (Odds Rat... | BeFree | 23021931 | Detail |
| 0.080 | breast carcinoma | We also confirmed that SNPs in FGFR2 and TNRC9 were associated with greater risk... | BeFree | 21791674 | Detail |
| 0.080 | breast carcinoma | Odds ratios for breast cancer were greatest for FGFR2-rs2981582 and TNRC9-rs3803... | BeFree | 20664043 | Detail |
| 0.230 | Malignant neoplasm of breast | Odds ratios for breast cancer were greatest for FGFR2-rs2981582 and TNRC9-rs3803... | BeFree | 20664043 | Detail |
| 0.240 | Malignant neoplasm of breast | We also confirmed that SNPs in FGFR2 and TNRC9 were associated with greater risk... | BeFree | 21791674 | Detail |
| 0.010 | breast carcinoma | We also confirmed that SNPs in FGFR2 and TNRC9 were associated with greater risk... | BeFree | 21791674 | Detail |
| 0.170 | Malignant neoplasm of breast | Odds ratios for breast cancer were greatest for FGFR2-rs2981582 and TNRC9-rs3803... | BeFree | 20664043 | Detail |
| 0.010 | breast carcinoma | A recent genome-wide association study has shown that common alleles at single n... | BeFree | 18355772 | Detail |
| 0.230 | Malignant neoplasm of breast | We also confirmed that SNPs in FGFR2 and TNRC9 were associated with greater risk... | BeFree | 21791674 | Detail |
| 0.031 | breast carcinoma | Odds ratios for breast cancer were greatest for FGFR2-rs2981582 and TNRC9-rs3803... | BeFree | 20664043 | Detail |
| 0.170 | Malignant neoplasm of breast | A recent genome-wide association study has shown that common alleles at single n... | BeFree | 18355772 | Detail |
| 0.128 | Malignant neoplasm of breast | Genome-wide association study identifies a common variant in RAD51B associated w... | GWASCAT | 23001122 | Detail |
| 0.002 | Secondary malignant neoplasm of bone | rs3803662 of TNRC9 gene has been shown to be the SNP with the strongest associat... | BeFree | 21996731 | Detail |
| <0.001 | Secondary malignant neoplasm of bone | rs3803662 of TNRC9 gene has been shown to be the SNP with the strongest associat... | BeFree | 21996731 | Detail |
| 0.010 | breast carcinoma | Recently, genetic polymorphism (rs3803662C>T) in TOX3 was reported to induce ... | BeFree | 24069142 | Detail |
| 0.128 | Malignant neoplasm of breast | Large-scale genotyping identifies 41 new loci associated with breast cancer risk... | GWASCAT | 23535729 | Detail |
| 0.004 | breast carcinoma | In conclusion, we show that there is little overlap between the breast cancer ri... | BeFree | 25611573 | Detail |
| <0.001 | Secondary malignant neoplasm of bone | rs3803662 is near the 5' end of TNRC9 , a high mobility group chromatin-associat... | BeFree | 17529974 | Detail |
| 0.170 | Malignant neoplasm of breast | The results suggest that the effect of the risk allele of rs3803662 is strongest... | BeFree | 23270421 | Detail |
| 0.128 | Malignant neoplasm of breast | The risk allele of SNP rs3803662 and the mRNA level of its closest genes TOX3 an... | BeFree | 23270421 | Detail |
| 0.010 | breast carcinoma | With the exception of rs3803662 (TOX3), there was no evidence that any of the SN... | BeFree | 22532573 | Detail |
| 0.010 | breast carcinoma | In conclusion, we show that there is little overlap between the breast cancer ri... | BeFree | 25611573 | Detail |
| 0.128 | Malignant neoplasm of breast | Genome-wide association study identifies novel breast cancer susceptibility loci... | GWASCAT | 17529967 | Detail |
| 0.128 | Malignant neoplasm of breast | Genome-wide association study identifies five new breast cancer susceptibility l... | GWASCAT | 20453838 | Detail |
| 0.170 | Malignant neoplasm of breast | Recently, genetic polymorphism (rs3803662C>T) in TOX3 was reported to induce ... | BeFree | 24069142 | Detail |
| 0.170 | Malignant neoplasm of breast | rs3803662 is near the 5' end of TNRC9 , a high mobility group chromatin-associat... | BeFree | 17529974 | Detail |
| 0.170 | Malignant neoplasm of breast | With the exception of rs3803662 (TOX3), there was no evidence that any of the SN... | BeFree | 22532573 | Detail |
| 0.010 | breast carcinoma | The results suggest that the effect of the risk allele of rs3803662 is strongest... | BeFree | 23270421 | Detail |
| 0.170 | Malignant neoplasm of breast | rs3803662 of TNRC9 gene has been shown to be the SNP with the strongest associat... | BeFree | 21996731 | Detail |
| 0.162 | Malignant neoplasm of breast | In conclusion, we show that there is little overlap between the breast cancer ri... | BeFree | 25611573 | Detail |
| 0.128 | Malignant neoplasm of breast | Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen ... | GWASCAT | 17529974 | Detail |
| 0.128 | Malignant neoplasm of breast | A combined analysis of genome-wide association studies in breast cancer. | GWASCAT | 20872241 | Detail |
| 0.128 | Malignant neoplasm of breast | Genome-wide association studies identify four ER negative-specific breast cancer... | GWASCAT | 23535733 | Detail |
| 0.010 | breast carcinoma | rs3803662 is near the 5' end of TNRC9 , a high mobility group chromatin-associat... | BeFree | 17529974 | Detail |
| 0.128 | Malignant neoplasm of breast | A multistage genome-wide association study in breast cancer identifies two new r... | GWASCAT | 19330030 | Detail |
| <0.001 | breast carcinoma | The risk allele of SNP rs3803662 and the mRNA level of its closest genes TOX3 an... | BeFree | 23270421 | Detail |
| 0.170 | Malignant neoplasm of breast | In conclusion, we show that there is little overlap between the breast cancer ri... | BeFree | 25611573 | Detail |
| 0.010 | breast carcinoma | rs3803662 of TNRC9 gene has been shown to be the SNP with the strongest associat... | BeFree | 21996731 | Detail |
| 0.010 | breast carcinoma | In the validation study using Stage I of the 2,273 cases and 2,052 controls, sev... | BeFree | 22452962 | Detail |
| 0.006 | breast carcinoma | In the validation study using Stage I of the 2,273 cases and 2,052 controls, sev... | BeFree | 22452962 | Detail |
| 0.166 | Malignant neoplasm of breast | In the validation study using Stage I of the 2,273 cases and 2,052 controls, sev... | BeFree | 22452962 | Detail |
| 0.031 | breast carcinoma | In the validation study using Stage I of the 2,273 cases and 2,052 controls, sev... | BeFree | 22452962 | Detail |
| 0.230 | Malignant neoplasm of breast | In the validation study using Stage I of the 2,273 cases and 2,052 controls, sev... | BeFree | 22452962 | Detail |
| 0.170 | Malignant neoplasm of breast | In the validation study using Stage I of the 2,273 cases and 2,052 controls, sev... | BeFree | 22452962 | Detail |
| 0.240 | Malignant neoplasm of breast | In the validation study using Stage I of the 2,273 cases and 2,052 controls, sev... | BeFree | 22452962 | Detail |
| 0.080 | breast carcinoma | In the validation study using Stage I of the 2,273 cases and 2,052 controls, sev... | BeFree | 22452962 | Detail |
| 0.006 | breast carcinoma | Confirmed BC risk SNPs rs17468277 (CASP8), rs1982073 (TGFB1), rs2981582 (FGFR2),... | BeFree | 22532573 | Detail |
| 0.131 | Malignant neoplasm of breast | We confirmed associations between rs13387042 (2q35), rs4973768 (SLC4A7), rs10941... | BeFree | 23893088 | Detail |
| 0.031 | breast carcinoma | We confirmed associations between rs13387042 (2q35), rs4973768 (SLC4A7), rs10941... | BeFree | 23893088 | Detail |
| 0.009 | breast carcinoma | Confirmed BC risk SNPs rs17468277 (CASP8), rs1982073 (TGFB1), rs2981582 (FGFR2),... | BeFree | 22532573 | Detail |
| 0.031 | breast carcinoma | Confirmed BC risk SNPs rs17468277 (CASP8), rs1982073 (TGFB1), rs2981582 (FGFR2),... | BeFree | 22532573 | Detail |
| 0.001 | Malignant neoplasm of breast | Confirmed BC risk SNPs rs17468277 (CASP8), rs1982073 (TGFB1), rs2981582 (FGFR2),... | BeFree | 22532573 | Detail |
| <0.001 | Carcinoma of male breast | Five SNPs showed a statistically significant association with male breast cancer... | BeFree | 21949660 | Detail |
| 0.162 | Malignant neoplasm of breast | Confirmed BC risk SNPs rs17468277 (CASP8), rs1982073 (TGFB1), rs2981582 (FGFR2),... | BeFree | 22532573 | Detail |
| 0.002 | breast carcinoma | Confirmed BC risk SNPs rs17468277 (CASP8), rs1982073 (TGFB1), rs2981582 (FGFR2),... | BeFree | 22532573 | Detail |
| 0.001 | breast carcinoma | Confirmed BC risk SNPs rs17468277 (CASP8), rs1982073 (TGFB1), rs2981582 (FGFR2),... | BeFree | 22532573 | Detail |
| 0.162 | Malignant neoplasm of breast | We confirmed associations between rs13387042 (2q35), rs4973768 (SLC4A7), rs10941... | BeFree | 23893088 | Detail |
| 0.002 | breast carcinoma | We confirmed associations between rs13387042 (2q35), rs4973768 (SLC4A7), rs10941... | BeFree | 23893088 | Detail |
| 0.004 | breast carcinoma | Confirmed BC risk SNPs rs17468277 (CASP8), rs1982073 (TGFB1), rs2981582 (FGFR2),... | BeFree | 22532573 | Detail |
| 0.170 | Malignant neoplasm of breast | We confirmed associations between rs13387042 (2q35), rs4973768 (SLC4A7), rs10941... | BeFree | 23893088 | Detail |
| 0.131 | Malignant neoplasm of breast | Confirmed BC risk SNPs rs17468277 (CASP8), rs1982073 (TGFB1), rs2981582 (FGFR2),... | BeFree | 22532573 | Detail |
| 0.230 | Malignant neoplasm of breast | We confirmed associations between rs13387042 (2q35), rs4973768 (SLC4A7), rs10941... | BeFree | 23893088 | Detail |
| <0.001 | breast carcinoma | We confirmed associations between rs13387042 (2q35), rs4973768 (SLC4A7), rs10941... | BeFree | 23893088 | Detail |
| 0.049 | Malignant neoplasm of breast | Confirmed BC risk SNPs rs17468277 (CASP8), rs1982073 (TGFB1), rs2981582 (FGFR2),... | BeFree | 22532573 | Detail |
| 0.166 | Malignant neoplasm of breast | Confirmed BC risk SNPs rs17468277 (CASP8), rs1982073 (TGFB1), rs2981582 (FGFR2),... | BeFree | 22532573 | Detail |
| 0.128 | Malignant neoplasm of breast | We confirmed associations between rs13387042 (2q35), rs4973768 (SLC4A7), rs10941... | BeFree | 23893088 | Detail |
| 0.090 | Malignant neoplasm of breast | Confirmed BC risk SNPs rs17468277 (CASP8), rs1982073 (TGFB1), rs2981582 (FGFR2),... | BeFree | 22532573 | Detail |
| 0.004 | breast carcinoma | We confirmed associations between rs13387042 (2q35), rs4973768 (SLC4A7), rs10941... | BeFree | 23893088 | Detail |
| 0.019 | breast carcinoma | Confirmed BC risk SNPs rs17468277 (CASP8), rs1982073 (TGFB1), rs2981582 (FGFR2),... | BeFree | 22532573 | Detail |
| 0.230 | Malignant neoplasm of breast | Confirmed BC risk SNPs rs17468277 (CASP8), rs1982073 (TGFB1), rs2981582 (FGFR2),... | BeFree | 22532573 | Detail |
| <0.001 | Malignant neoplasm of male breast | Five SNPs showed a statistically significant association with male breast cancer... | BeFree | 21949660 | Detail |
| 0.010 | breast carcinoma | We confirmed associations between rs13387042 (2q35), rs4973768 (SLC4A7), rs10941... | BeFree | 23893088 | Detail |
Annotation
Annotations
| Descrption | Source | Links |
|---|---|---|
| We focus on TNRC9 rs3803662, FGFR2 rs1219648 and rs2981582, MAP3K1 rs889312, and 2q35 rs13387042, to... | DisGeNET | Detail |
| We focus on TNRC9 rs3803662, FGFR2 rs1219648 and rs2981582, MAP3K1 rs889312, and 2q35 rs13387042, to... | DisGeNET | Detail |
| Six of the previously identified SNPs showed a statistically significant association with breast can... | DisGeNET | Detail |
| Six of the previously identified SNPs showed a statistically significant association with breast can... | DisGeNET | Detail |
| Six of the previously identified SNPs showed a statistically significant association with breast can... | DisGeNET | Detail |
| Six of the previously identified SNPs showed a statistically significant association with breast can... | DisGeNET | Detail |
| Six of the previously identified SNPs showed a statistically significant association with breast can... | DisGeNET | Detail |
| Six of the previously identified SNPs showed a statistically significant association with breast can... | DisGeNET | Detail |
| Six of the previously identified SNPs showed a statistically significant association with breast can... | DisGeNET | Detail |
| Six of the previously identified SNPs showed a statistically significant association with breast can... | DisGeNET | Detail |
| We genotyped 17 germline SNPs (FGFR2-rs2981582, FGFR2-rs3750817, TNRC9-rs3803662, 2q35-rs13387042, M... | DisGeNET | Detail |
| We genotyped 17 germline SNPs (FGFR2-rs2981582, FGFR2-rs3750817, TNRC9-rs3803662, 2q35-rs13387042, M... | DisGeNET | Detail |
| We identified six single-nucleotide polymorphisms, including rs2046210 (ESR1), rs12662670 (ESR1), rs... | DisGeNET | Detail |
| We identified six single-nucleotide polymorphisms, including rs2046210 (ESR1), rs12662670 (ESR1), rs... | DisGeNET | Detail |
| We identified six single-nucleotide polymorphisms, including rs2046210 (ESR1), rs12662670 (ESR1), rs... | DisGeNET | Detail |
| We genotyped 17 germline SNPs (FGFR2-rs2981582, FGFR2-rs3750817, TNRC9-rs3803662, 2q35-rs13387042, M... | DisGeNET | Detail |
| We genotyped 17 germline SNPs (FGFR2-rs2981582, FGFR2-rs3750817, TNRC9-rs3803662, 2q35-rs13387042, M... | DisGeNET | Detail |
| We genotyped 17 germline SNPs (FGFR2-rs2981582, FGFR2-rs3750817, TNRC9-rs3803662, 2q35-rs13387042, M... | DisGeNET | Detail |
| Genome-wide association study of breast cancer in the Japanese population. | DisGeNET | Detail |
| We genotyped 17 germline SNPs (FGFR2-rs2981582, FGFR2-rs3750817, TNRC9-rs3803662, 2q35-rs13387042, M... | DisGeNET | Detail |
| In the present study, we evaluated the association between rs3803662 (TOX3, also known as TNRC9), rs... | DisGeNET | Detail |
| In the present study, we evaluated the association between rs3803662 (TOX3, also known as TNRC9), rs... | DisGeNET | Detail |
| Comparing the ORs for male breast cancer with the published ORs for female breast cancer, three SNPs... | DisGeNET | Detail |
| Comparing the ORs for male breast cancer with the published ORs for female breast cancer, three SNPs... | DisGeNET | Detail |
| Comparing the ORs for male breast cancer with the published ORs for female breast cancer, three SNPs... | DisGeNET | Detail |
| Comparing the ORs for male breast cancer with the published ORs for female breast cancer, three SNPs... | DisGeNET | Detail |
| Comparing the ORs for male breast cancer with the published ORs for female breast cancer, three SNPs... | DisGeNET | Detail |
| Comparing the ORs for male breast cancer with the published ORs for female breast cancer, three SNPs... | DisGeNET | Detail |
| Comparing the ORs for male breast cancer with the published ORs for female breast cancer, three SNPs... | DisGeNET | Detail |
| Comparing the ORs for male breast cancer with the published ORs for female breast cancer, three SNPs... | DisGeNET | Detail |
| By multivariate logistic regression models, we found a significant increased MBC risk for 3 SNPs, in... | DisGeNET | Detail |
| By multivariate logistic regression models, we found a significant increased MBC risk for 3 SNPs, in... | DisGeNET | Detail |
| By multivariate logistic regression models, we found a significant increased MBC risk for 3 SNPs, in... | DisGeNET | Detail |
| By multivariate logistic regression models, we found a significant increased MBC risk for 3 SNPs, in... | DisGeNET | Detail |
| Initially, three SNPs (rs2107425 in MRPL23, rs7313833 in PTHLH, rs3803662 in TNRC9) were weakly asso... | DisGeNET | Detail |
| Initially, three SNPs (rs2107425 in MRPL23, rs7313833 in PTHLH, rs3803662 in TNRC9) were weakly asso... | DisGeNET | Detail |
| Initially, three SNPs (rs2107425 in MRPL23, rs7313833 in PTHLH, rs3803662 in TNRC9) were weakly asso... | DisGeNET | Detail |
| Initially, three SNPs (rs2107425 in MRPL23, rs7313833 in PTHLH, rs3803662 in TNRC9) were weakly asso... | DisGeNET | Detail |
| Initially, three SNPs (rs2107425 in MRPL23, rs7313833 in PTHLH, rs3803662 in TNRC9) were weakly asso... | DisGeNET | Detail |
| Initially, three SNPs (rs2107425 in MRPL23, rs7313833 in PTHLH, rs3803662 in TNRC9) were weakly asso... | DisGeNET | Detail |
| Initially, three SNPs (rs2107425 in MRPL23, rs7313833 in PTHLH, rs3803662 in TNRC9) were weakly asso... | DisGeNET | Detail |
| Initially, three SNPs (rs2107425 in MRPL23, rs7313833 in PTHLH, rs3803662 in TNRC9) were weakly asso... | DisGeNET | Detail |
| Evidence of association with MD was found for variant rs3803662 (TOX3) (Odds Ratio (OR)=1.13, 95% Co... | DisGeNET | Detail |
| We also confirmed that SNPs in FGFR2 and TNRC9 were associated with greater risk of estrogen recepto... | DisGeNET | Detail |
| We also confirmed that SNPs in FGFR2 and TNRC9 were associated with greater risk of estrogen recepto... | DisGeNET | Detail |
| Odds ratios for breast cancer were greatest for FGFR2-rs2981582 and TNRC9-rs3803662 and, for these 2... | DisGeNET | Detail |
| Odds ratios for breast cancer were greatest for FGFR2-rs2981582 and TNRC9-rs3803662 and, for these 2... | DisGeNET | Detail |
| Evidence of association with MD was found for variant rs3803662 (TOX3) (Odds Ratio (OR)=1.13, 95% Co... | DisGeNET | Detail |
| We also confirmed that SNPs in FGFR2 and TNRC9 were associated with greater risk of estrogen recepto... | DisGeNET | Detail |
| Odds ratios for breast cancer were greatest for FGFR2-rs2981582 and TNRC9-rs3803662 and, for these 2... | DisGeNET | Detail |
| Odds ratios for breast cancer were greatest for FGFR2-rs2981582 and TNRC9-rs3803662 and, for these 2... | DisGeNET | Detail |
| We also confirmed that SNPs in FGFR2 and TNRC9 were associated with greater risk of estrogen recepto... | DisGeNET | Detail |
| We also confirmed that SNPs in FGFR2 and TNRC9 were associated with greater risk of estrogen recepto... | DisGeNET | Detail |
| Odds ratios for breast cancer were greatest for FGFR2-rs2981582 and TNRC9-rs3803662 and, for these 2... | DisGeNET | Detail |
| A recent genome-wide association study has shown that common alleles at single nucleotide polymorphi... | DisGeNET | Detail |
| We also confirmed that SNPs in FGFR2 and TNRC9 were associated with greater risk of estrogen recepto... | DisGeNET | Detail |
| Odds ratios for breast cancer were greatest for FGFR2-rs2981582 and TNRC9-rs3803662 and, for these 2... | DisGeNET | Detail |
| A recent genome-wide association study has shown that common alleles at single nucleotide polymorphi... | DisGeNET | Detail |
| Genome-wide association study identifies a common variant in RAD51B associated with male breast canc... | DisGeNET | Detail |
| rs3803662 of TNRC9 gene has been shown to be the SNP with the strongest association with BC, in part... | DisGeNET | Detail |
| rs3803662 of TNRC9 gene has been shown to be the SNP with the strongest association with BC, in part... | DisGeNET | Detail |
| Recently, genetic polymorphism (rs3803662C>T) in TOX3 was reported to induce the risk of breast c... | DisGeNET | Detail |
| Large-scale genotyping identifies 41 new loci associated with breast cancer risk. | DisGeNET | Detail |
| In conclusion, we show that there is little overlap between the breast cancer risk single nucleotide... | DisGeNET | Detail |
| rs3803662 is near the 5' end of TNRC9 , a high mobility group chromatin-associated protein whose exp... | DisGeNET | Detail |
| The results suggest that the effect of the risk allele of rs3803662 is strongest in luminal A tumour... | DisGeNET | Detail |
| The risk allele of SNP rs3803662 and the mRNA level of its closest genes TOX3 and LOC643714 predict ... | DisGeNET | Detail |
| With the exception of rs3803662 (TOX3), there was no evidence that any of the SNPs associated with B... | DisGeNET | Detail |
| In conclusion, we show that there is little overlap between the breast cancer risk single nucleotide... | DisGeNET | Detail |
| Genome-wide association study identifies novel breast cancer susceptibility loci. | DisGeNET | Detail |
| Genome-wide association study identifies five new breast cancer susceptibility loci. | DisGeNET | Detail |
| Recently, genetic polymorphism (rs3803662C>T) in TOX3 was reported to induce the risk of breast c... | DisGeNET | Detail |
| rs3803662 is near the 5' end of TNRC9 , a high mobility group chromatin-associated protein whose exp... | DisGeNET | Detail |
| With the exception of rs3803662 (TOX3), there was no evidence that any of the SNPs associated with B... | DisGeNET | Detail |
| The results suggest that the effect of the risk allele of rs3803662 is strongest in luminal A tumour... | DisGeNET | Detail |
| rs3803662 of TNRC9 gene has been shown to be the SNP with the strongest association with BC, in part... | DisGeNET | Detail |
| In conclusion, we show that there is little overlap between the breast cancer risk single nucleotide... | DisGeNET | Detail |
| Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive br... | DisGeNET | Detail |
| A combined analysis of genome-wide association studies in breast cancer. | DisGeNET | Detail |
| Genome-wide association studies identify four ER negative-specific breast cancer risk loci. | DisGeNET | Detail |
| rs3803662 is near the 5' end of TNRC9 , a high mobility group chromatin-associated protein whose exp... | DisGeNET | Detail |
| A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.... | DisGeNET | Detail |
| The risk allele of SNP rs3803662 and the mRNA level of its closest genes TOX3 and LOC643714 predict ... | DisGeNET | Detail |
| In conclusion, we show that there is little overlap between the breast cancer risk single nucleotide... | DisGeNET | Detail |
| rs3803662 of TNRC9 gene has been shown to be the SNP with the strongest association with BC, in part... | DisGeNET | Detail |
| In the validation study using Stage I of the 2,273 cases and 2,052 controls, seven GWAS-identified l... | DisGeNET | Detail |
| In the validation study using Stage I of the 2,273 cases and 2,052 controls, seven GWAS-identified l... | DisGeNET | Detail |
| In the validation study using Stage I of the 2,273 cases and 2,052 controls, seven GWAS-identified l... | DisGeNET | Detail |
| In the validation study using Stage I of the 2,273 cases and 2,052 controls, seven GWAS-identified l... | DisGeNET | Detail |
| In the validation study using Stage I of the 2,273 cases and 2,052 controls, seven GWAS-identified l... | DisGeNET | Detail |
| In the validation study using Stage I of the 2,273 cases and 2,052 controls, seven GWAS-identified l... | DisGeNET | Detail |
| In the validation study using Stage I of the 2,273 cases and 2,052 controls, seven GWAS-identified l... | DisGeNET | Detail |
| In the validation study using Stage I of the 2,273 cases and 2,052 controls, seven GWAS-identified l... | DisGeNET | Detail |
| Confirmed BC risk SNPs rs17468277 (CASP8), rs1982073 (TGFB1), rs2981582 (FGFR2), rs13281615 (8q24), ... | DisGeNET | Detail |
| We confirmed associations between rs13387042 (2q35), rs4973768 (SLC4A7), rs10941679 (5p12), rs298158... | DisGeNET | Detail |
| We confirmed associations between rs13387042 (2q35), rs4973768 (SLC4A7), rs10941679 (5p12), rs298158... | DisGeNET | Detail |
| Confirmed BC risk SNPs rs17468277 (CASP8), rs1982073 (TGFB1), rs2981582 (FGFR2), rs13281615 (8q24), ... | DisGeNET | Detail |
| Confirmed BC risk SNPs rs17468277 (CASP8), rs1982073 (TGFB1), rs2981582 (FGFR2), rs13281615 (8q24), ... | DisGeNET | Detail |
| Confirmed BC risk SNPs rs17468277 (CASP8), rs1982073 (TGFB1), rs2981582 (FGFR2), rs13281615 (8q24), ... | DisGeNET | Detail |
| Five SNPs showed a statistically significant association with male breast cancer: rs13387042 (2q35) ... | DisGeNET | Detail |
| Confirmed BC risk SNPs rs17468277 (CASP8), rs1982073 (TGFB1), rs2981582 (FGFR2), rs13281615 (8q24), ... | DisGeNET | Detail |
| Confirmed BC risk SNPs rs17468277 (CASP8), rs1982073 (TGFB1), rs2981582 (FGFR2), rs13281615 (8q24), ... | DisGeNET | Detail |
| Confirmed BC risk SNPs rs17468277 (CASP8), rs1982073 (TGFB1), rs2981582 (FGFR2), rs13281615 (8q24), ... | DisGeNET | Detail |
| We confirmed associations between rs13387042 (2q35), rs4973768 (SLC4A7), rs10941679 (5p12), rs298158... | DisGeNET | Detail |
| We confirmed associations between rs13387042 (2q35), rs4973768 (SLC4A7), rs10941679 (5p12), rs298158... | DisGeNET | Detail |
| Confirmed BC risk SNPs rs17468277 (CASP8), rs1982073 (TGFB1), rs2981582 (FGFR2), rs13281615 (8q24), ... | DisGeNET | Detail |
| We confirmed associations between rs13387042 (2q35), rs4973768 (SLC4A7), rs10941679 (5p12), rs298158... | DisGeNET | Detail |
| Confirmed BC risk SNPs rs17468277 (CASP8), rs1982073 (TGFB1), rs2981582 (FGFR2), rs13281615 (8q24), ... | DisGeNET | Detail |
| We confirmed associations between rs13387042 (2q35), rs4973768 (SLC4A7), rs10941679 (5p12), rs298158... | DisGeNET | Detail |
| We confirmed associations between rs13387042 (2q35), rs4973768 (SLC4A7), rs10941679 (5p12), rs298158... | DisGeNET | Detail |
| Confirmed BC risk SNPs rs17468277 (CASP8), rs1982073 (TGFB1), rs2981582 (FGFR2), rs13281615 (8q24), ... | DisGeNET | Detail |
| Confirmed BC risk SNPs rs17468277 (CASP8), rs1982073 (TGFB1), rs2981582 (FGFR2), rs13281615 (8q24), ... | DisGeNET | Detail |
| We confirmed associations between rs13387042 (2q35), rs4973768 (SLC4A7), rs10941679 (5p12), rs298158... | DisGeNET | Detail |
| Confirmed BC risk SNPs rs17468277 (CASP8), rs1982073 (TGFB1), rs2981582 (FGFR2), rs13281615 (8q24), ... | DisGeNET | Detail |
| We confirmed associations between rs13387042 (2q35), rs4973768 (SLC4A7), rs10941679 (5p12), rs298158... | DisGeNET | Detail |
| Confirmed BC risk SNPs rs17468277 (CASP8), rs1982073 (TGFB1), rs2981582 (FGFR2), rs13281615 (8q24), ... | DisGeNET | Detail |
| Confirmed BC risk SNPs rs17468277 (CASP8), rs1982073 (TGFB1), rs2981582 (FGFR2), rs13281615 (8q24), ... | DisGeNET | Detail |
| Five SNPs showed a statistically significant association with male breast cancer: rs13387042 (2q35) ... | DisGeNET | Detail |
| We confirmed associations between rs13387042 (2q35), rs4973768 (SLC4A7), rs10941679 (5p12), rs298158... | DisGeNET | Detail |
Overlapped Transcript Coordinates
| Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
|---|
Overlapped Transcript
| Gene | Transcript ID | Chromosome | Start | Stop | Links |
|---|
- Gene
- -
- dbSNP
- rs3803662 dbSNP
- Genome
- hg38
- Position
- chr16:52,552,429-52,552,429
- Variant Type
- snv
- Reference Allele
- A
- Alternative Allele
- G
- ToMMo VCF FILTER column value (ToMMo 8.3KJPN Allele Frequency Panel(v20200831))
- PASS
- Total VCF ID column value (ToMMo 8.3KJPN Allele Frequency Panel(v20200831))
- rs3803662
- Allele frequency, for each ALT allele (ToMMo 8.3KJPN Allele Frequency Panel(v20200831))
- 0.4758
- Allele count in genotypes, for each ALT allele (ToMMo 8.3KJPN Allele Frequency Panel(v20200831))
- 7974
- Total number of alleles in called genotypes (ToMMo 8.3KJPN Allele Frequency Panel(v20200831))
- 16760
Genome browser